本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Summit Therapeutics PLC

17.30
-0.1000-0.57%
盤後17.28-0.0200-0.12%19:53 EDT
成交量:608.79萬
成交額:1.06億
市值:138.01億
市盈率:-15.48
高:17.75
開:17.50
低:17.11
收:17.40
52周最高:29.23
52周最低:12.07
股本:7.98億
流通股本:1.52億
量比:1.16
換手率:4.00%
股息:- -
股息率:- -
每股收益(TTM):-1.1177
每股收益(LYR):-1.4439
淨資產收益率:-192.50%
總資產收益率:-101.61%
市淨率:21.91
市盈率(LYR):-11.98

資料載入中...

2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

SEC問詢函

[Cover]Correspondence
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露報告

General statement of acquisition of beneficial ownership
2019/01/18

非美公司披露報告

Notice of Exempt Offering of Securities, item 06b
2019/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/22

非美公司披露報告